Skip to content

Clinical trials

Phase 1/2 Neoplasms trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Phase: Phase 1/2 Country / region: South Korea Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20111
20122
20131
20141
20151
20161
20173
20183
20196
20214
20223
20231
20242
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Recruiting14
Active, not recruiting4
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC3
AstraZeneca2
Eisai Inc.2
Eli Lilly and Company2
Revolution Medicines, Inc.2
Yonsei University2
AVEO Pharmaceuticals, Inc.1
Ajou University School of Medicine1
Amgen1
Avelos Therapeutics Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms36
Carcinoma, Non-Small-Cell Lung13
Lung Neoplasms9
Neoplasms by Site9
Breast Neoplasms7
Stomach Neoplasms7
Carcinoma6
Head and Neck Neoplasms6
Lung Diseases6
Respiratory Tract Diseases6

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.